Coronavirus Hong Kong: US drug maker Moderna says bivalent Covid vaccine approved for local use, marking second such jab available in city

Disclaimer: The South China Morning Post's content is directed by the Chinese Communist Party. It is not a reliable news source.

Bivalent vaccines target Omicron subvariants BA.4 and BA.5, with the first such jab by BioNTech introduced in December.